Public Health
publicado em 21/01/2013 às 17h32:00
   Dê o seu voto:

More than 400 types of medicines come 35% cheaper in Brazil

Economic regulation allowed drugs arrived in the country with lower prices than those pleaded by industries

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



Foto: Ministério da Saúde
Due to economic regulation drugs had on average 35% cheaper to the consumer
  « Previous
next »  
Due to economic regulation drugs had on average 35% cheaper to the consumer

Study Anvisa analyzed maximums established by the Board of Market Regulation of Medicines of 433 products such as tablets, ointments and syrups, among others, in over a thousand presentations. The economic regulation allowed these drugs came at the hands of Brazilians with prices on average 35% cheaper than those pleaded by foreign pharmaceutical industries.

According to the Manager of Economic Evaluation of New Technologies Anvisa, Gabrielle Troncoso, in most cases, companies ask for prices higher than those that end up being authorized by the government. The study indicated that economic regulation has been effective in reducing the entry prices of medicines in our country, says the manager.

Medicines (category I) molecules with innovative patent in Brazil and evidence of therapeutic gain compared to drugs already used for the same indication were minority (3.24%) of products launched by the pharmaceutical industry in Brazil, in the period. The majority (45.03%) has no patent or proving therapeutic gain (category II). The new combinations of active ingredients already in the country and new medications in dosage forms amounted to 36.72% of the products analyzed.

In the case of Class I, set maximum prices were 19% lower than those required by the pharmaceutical industry. For Class II, the reduction was 37%. The foreign-funded enterprises accounted for almost 82% of companies that had products classified as Class I or II.

The new combinations of active ingredients already in the country and in new drug introductions (class V) had a 38% difference between the price fixed by the industries and pleaded. Have the drugs classified as ignored and those who could not be classified in any of the categories established by law, to lower prices was 35% and 45% respectively.

Source: Isaude.net
   Palavras-chave:   ANVISA    Prices    Medication    Pharmaceutical industry    Economic regulation   
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: More than 400 types of medicines come 35% cheaper in Brazil
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: More than 400 types of medicines come 35% cheaper in Brazil


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
ANVISA    prices    medication    pharmaceutical industry    economic regulation   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.